Some parents swear by tapeworm concoctions to ease symptoms of autism. Could “helminth therapies” go mainstream?   While there’s no proof that they work, there have been glowing anecdotal reports. Illegal to distribute in the US, one parent had them shipped from Thailand—…

Modern medicine is facing the convergence of 2 major problems: the rise of antibiotic resistance and the fall of efforts to find badly needed replacements, write Allan Coukell and Helen W. Boucher. In 2018 alone, 3 Big Pharma firms halted antibiotics R&D; others have…

In the urgent search for multipronged, coordinated solutions to the opioid epidemic ravaging the U.S., blockchain might be just the powerful weapon we need.

The ads take clear aim at stressed, hassled moms. “Breathe,” one ad encourages moms. “Pour a glass of wine … Prepare your family the chicken. Whether the label says ‘no antibiotics’ or not, the meat and milk you buy is free of harmful residues from antibiotics.”

Editor’s Note: This week we will highlight 5 takes on how can we reduce drug prices while preserving robust research and development, from the fall issue of Hopkins Bloomberg Public Health Magazine. Read the complete set here.

Although Big Pharma has shown little interest in developing male birth control, scientists continue to forge ahead with numerous new contraceptive techniques, including one that may start human trials within the next year. If successful, those innovations could cut into…

Research-based pharmaceutical companies have a bad reputation across the globe.   To repair their image while also tapping new markets among populations that are typically underserved, companies should turn “access to medicine” into a business strategy, argues Damiano de…

Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of…

Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of…

The costly and risky process of bringing new drugs to market is typically cited to explain away rising prescription drug costs—but new research chips away at this argument. Harvard Medical School researchers found that market forces, such as government-protected monopolies…